gadolinium dtpa has been researched along with Nausea in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breuer, J; Dohanish, S; Endrikat, J; Kim, SY; Sakaguchi, T | 1 |
Au Yeung, MC; Lee, CM; Li, A; Wong, CS; Wong, MK | 1 |
Hanna, RF; Middleton, MS; Shiehmorteza, M | 1 |
Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
1 review(s) available for gadolinium dtpa and Nausea
Article | Year |
---|---|
Can gadopentetate dimeglumine be safely administered more rapidly than the FDA-approved injection rate for liver imaging?
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Contrast Media; Drug Administration Schedule; Drug Approval; Female; Gadolinium DTPA; Headache; Humans; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; PubMed; United States; United States Food and Drug Administration | 2007 |
2 trial(s) available for gadolinium dtpa and Nausea
Article | Year |
---|---|
Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients.
Topics: Adolescent; Adult; Age Distribution; Aged; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Female; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Internationality; Kidney Diseases; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Prevalence; Risk Factors; Sex Distribution; Treatment Outcome; Young Adult | 2016 |
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |
1 other study(ies) available for gadolinium dtpa and Nausea
Article | Year |
---|---|
Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
Topics: Acute Disease; Adolescent; Adult; Aged; Anaphylaxis; Asthma; Child; Contrast Media; Drug Hypersensitivity; Dyspnea; Female; Gadolinium DTPA; Hong Kong; Humans; Hypersensitivity, Delayed; Incidence; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Osmolar Concentration; Recurrence; Retrospective Studies; Urticaria | 2006 |